Androgen induced oxidative stress inhibitors

Details for Australian Patent Application No. 2011239432 (hide)

Owner Colby Pharmaceutical Company

Inventors Basu, Hirak S.; Zarling, David A.; Wilding, George; Mehraein-Ghomi, Farideh; Church, Dawn R.

Agent Wrays

Pub. Number AU-A-2011239432

PCT Pub. Number WO2011/130692

Priority 61/325,251 16.04.10 US; 61/471,047 01.04.11 US

Filing date 15 April 2011

Wipo publication date 20 October 2011

International Classifications

C07D 311/42 Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

A61K 31/352 - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/407 - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 35/00 Antineoplastic agents

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

25 October 2012 PCT application entered the National Phase

  PCT publication WO2011/130692 Priority application(s): WO2011/130692

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011239447-Compounds, compositions, and methods for reducing or eliminating bitter taste

2011239402-Compositions and methods for treating COPD exacerbation